D-1291-2020 Class III Terminated

Recalled by UNICHEM PHARMACEUTICALS USA INC — East Brunswick, NJ

FDA drug recall D-1291-2020 was initiated by UNICHEM PHARMACEUTICALS USA INC on May 26, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container. The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 190,992 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 17, 2020
Initiation Date
May 26, 2020
Termination Date
Jan 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
190,992 bottles

Product description

Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for : Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-135-01

Reason for recall

Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.

Distribution pattern

Nationwide within the United States

Code information

Lot #: GCLL19034, GCLL19035, GCLL19036, Exp. 4/30/2021; GCLL19044, Exp. 6/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1291-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1291-2020. Report a data issue: hello@regdatalab.com.